15 min listen
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells
FromVJHemOnc Podcast
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells
FromVJHemOnc Podcast
ratings:
Length:
18 minutes
Released:
Nov 30, 2022
Format:
Podcast episode
Description
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in...
The post iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells appeared first on VJHemOnc.
The post iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells appeared first on VJHemOnc.
Released:
Nov 30, 2022
Format:
Podcast episode
Titles in the series (100)
Acute leukemias discussion: what does genomics and epigenomics tell us about patient management?: A stimulating session on the implications of genomic data for the management of acute myeloid leukemia (AML) and acute lymphoblastic... by VJHemOnc Podcast